| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1681* | 2020 |
| Whole-genome landscape of pancreatic neuroendocrine tumours A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ... Nature 543 (7643), 65-71, 2017 | 841 | 2017 |
| Derangement of immune responses by myeloid suppressor cells P Serafini, C De Santo, I Marigo, S Cingarlini, L Dolcetti, G Gallina, ... Cancer Immunology, Immunotherapy 53, 64-72, 2004 | 436 | 2004 |
| IFN-γ-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer M Martini, MG Testi, M Pasetto, MC Picchio, G Innamorati, M Mazzocco, ... Vaccine 28 (20), 3548-3557, 2010 | 162 | 2010 |
| A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy G Butturini, I Damoli, L Crepaz, G Malleo, G Marchegiani, D Daskalaki, ... Surgical endoscopy 29, 3163-3170, 2015 | 133 | 2015 |
| Anti‐tumor effects of toxins targeted to the prostate specific membrane antigen G Fracasso, G Bellisola, S Cingarlini, D Castelletti, T Prayer‐Galetti, ... The Prostate 53 (1), 9-23, 2002 | 127 | 2002 |
| Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components M Scardoni, E Vittoria, M Volante, B Rusev, S Bersani, A Mafficini, ... Neuroendocrinology 100 (4), 310-316, 2015 | 124 | 2015 |
| Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE M Sansovini, S Severi, A Ianniello, S Nicolini, L Fantini, E Mezzenga, ... European journal of nuclear medicine and molecular imaging 44, 490-499, 2017 | 112 | 2017 |
| The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1 M Colombatti, S Grasso, A Porzia, G Fracasso, MT Scupoli, S Cingarlini, ... PloS one 4 (2), e4608, 2009 | 105 | 2009 |
| Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study MV Davi', E Cosaro, S Piacentini, G Reimondo, N Albiger, G Arnaldi, ... European journal of endocrinology 176 (4), 453-461, 2017 | 89 | 2017 |
| PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models G Zuccolotto, G Fracasso, A Merlo, IM Montagner, M Rondina, S Bobisse, ... PloS one 9 (10), e109427, 2014 | 84 | 2014 |
| A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer B Frigerio, G Fracasso, E Luison, S Cingarlini, M Mortarino, A Coliva, ... European Journal of Cancer 49 (9), 2223-2232, 2013 | 80 | 2013 |
| Pulmonary adenocarcinoma with enteric differentiation: immunohistochemistry and molecular morphology A Nottegar, F Tabbò, C Luchini, M Brunelli, E Bria, N Veronese, A Santo, ... Applied Immunohistochemistry & Molecular Morphology 26 (6), 383-387, 2018 | 76 | 2018 |
| Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size WM Hackeng, LAA Brosens, JY Kim, R O'Sullivan, YN Sung, TC Liu, ... Gut 71 (5), 961-973, 2022 | 75 | 2022 |
| Metformin use is associated with longer progression-free survival of patients with diabetes and pancreatic neuroendocrine tumors receiving everolimus and/or somatostatin analogues S Pusceddu, C Vernieri, M Di Maio, R Marconcini, F Spada, S Massironi, ... Gastroenterology 155 (2), 479-489. e7, 2018 | 70 | 2018 |
| Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? R De Robertis, B Maris, N Cardobi, P Tinazzi Martini, S Gobbo, P Capelli, ... European radiology 28, 2582-2591, 2018 | 70 | 2018 |
| CT enhancement and 3D texture analysis of pancreatic neuroendocrine neoplasms M D’Onofrio, V Ciaravino, N Cardobi, R De Robertis, S Cingarlini, ... Scientific Reports 9 (1), 2176, 2019 | 60 | 2019 |
| Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors A Pulvirenti, AA Javed, L Landoni, NB Jamieson, JF Chou, M Miotto, J He, ... Annals of surgery 274 (6), 1051-1057, 2021 | 59 | 2021 |
| The evolution of surgical strategies for pancreatic neuroendocrine tumors (Pan-NENs): time-trend and outcome analysis from 587 consecutive resections at a high-volume institution L Landoni, G Marchegiani, T Pollini, S Cingarlini, M D’Onofrio, P Capelli, ... Annals of surgery 269 (4), 725-732, 2019 | 59 | 2019 |
| Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? G Marchegiani, L Landoni, S Andrianello, G Masini, S Cingarlini, ... Neuroendocrinology 108 (3), 161-171, 2019 | 57 | 2019 |
